183 related articles for article (PubMed ID: 32350689)
1. Disease mapping of early- and late-stage cancer to monitor inequalities in early detection: a study of cutaneous malignant melanoma.
Strömberg U; Parkes BL; Holmén A; Peterson S; Holmberg E; Baigi A; Piel FB
Eur J Epidemiol; 2020 Jun; 35(6):537-547. PubMed ID: 32350689
[TBL] [Abstract][Full Text] [Related]
2. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous malignant melanoma show geographic and socioeconomic disparities in stage at diagnosis and excess mortality.
Strömberg U; Peterson S; Holmberg E; Holmén A; Persson B; Sandberg C; Nilbert M
Acta Oncol; 2016 Aug; 55(8):993-1000. PubMed ID: 26935355
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study.
Ghazawi FM; Cyr J; Darwich R; Le M; Rahme E; Moreau L; Netchiporouk E; Zubarev A; Roshdy O; Glassman SJ; Sasseville D; Litvinov IV
J Am Acad Dermatol; 2019 Feb; 80(2):448-459. PubMed ID: 30092328
[TBL] [Abstract][Full Text] [Related]
5. Later stage at diagnosis and worse survival in cutaneous malignant melanoma among men living alone: a nationwide population-based study from Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Carstensen J; Hansson J
J Clin Oncol; 2014 May; 32(13):1356-64. PubMed ID: 24687828
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous malignant melanoma in south Sweden 1965, 1975, and 1985. A histopathologic review.
Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
Cancer; 1994 Mar; 73(6):1625-30. PubMed ID: 8156490
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and disease-specific survival among immigrants diagnosed with cutaneous malignant melanoma in Sweden.
Simberg-Danell C; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Carstensen J; Hansson J; Eriksson H
Int J Cancer; 2016 Aug; 139(3):543-53. PubMed ID: 27004457
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Orfanos CE
Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
[TBL] [Abstract][Full Text] [Related]
9. Spatial disparities in melanoma incidence and prognosis with consideration to stage at diagnosis, gender and marital status.
Strömberg U; Holmén A; Peterson S
Spat Spatiotemporal Epidemiol; 2016 Nov; 19():21-27. PubMed ID: 27839577
[TBL] [Abstract][Full Text] [Related]
10. Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England.
Shack L; Jordan C; Thomson CS; Mak V; Møller H;
BMC Cancer; 2008 Sep; 8():271. PubMed ID: 18822122
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological characteristics of cutaneous malignant melanoma of the head and neck--a population-based study.
Gillgren P; Månsson-Brahme E; Frisell J; Johansson H; Larsson O; Ringborg U
Acta Oncol; 1999; 38(8):1069-74. PubMed ID: 10665765
[TBL] [Abstract][Full Text] [Related]
12. Stage-specific direct health care costs in patients with cutaneous malignant melanoma.
Lyth J; Carstensen J; Synnerstad I; Lindholm C
J Eur Acad Dermatol Venereol; 2016 May; 30(5):789-93. PubMed ID: 25807966
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous malignant melanoma--clinical epidemiology and survival.
Nair MK; Varghese C; Mahadevan S; Cherian T; Joseph F
J Indian Med Assoc; 1998 Jan; 96(1):19-20, 28. PubMed ID: 9601186
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of incidence and clinical features of cutaneous malignant melanoma in Crete (Greece) and southern Germany (central Baden-Württemberg).
Lasithiotakis K; Leiter U; Krüger-Krasagakis S; Tosca A; Garbe C
Br J Dermatol; 2006 Jun; 154(6):1123-7. PubMed ID: 16704644
[TBL] [Abstract][Full Text] [Related]
15. Estimating the cure proportion of malignant melanoma, an alternative approach to assess long term survival: a population-based study.
Andersson TM; Eriksson H; Hansson J; Månsson-Brahme E; Dickman PW; Eloranta S; Lambe M; Lambert PC
Cancer Epidemiol; 2014 Feb; 38(1):93-9. PubMed ID: 24447700
[TBL] [Abstract][Full Text] [Related]
16. Incidence, Mortality, and Spatiotemporal Distribution of Cutaneous Malignant Melanoma Cases Across Canada.
Ghazawi FM; Le M; Lagacé F; Cyr J; Alghazawi N; Zubarev A; Roy SF; Rahme E; Netchiporouk E; Roshdy O; Glassman SJ; Sasseville D; Litvinov IV
J Cutan Med Surg; 2019; 23(4):394-412. PubMed ID: 31132871
[TBL] [Abstract][Full Text] [Related]
17. Incidence of cutaneous melanoma in Western Sweden, 1970-2007.
Claeson M; Andersson EM; Wallin M; Wastensson G; Wennberg AM; Paoli J; Gonzalez H
Melanoma Res; 2012 Oct; 22(5):392-8. PubMed ID: 22955011
[TBL] [Abstract][Full Text] [Related]
18. Time trends in features of cutaneous melanoma at diagnosis: central-south Italy, 1962-1991.
Cavalieri R; Macchini V; Mostaccioli S; Sonego G; Ferranti G; Corona R; Fucci M; Marzolini F; Rosmini F; Pasquini P
Ann Ist Super Sanita; 1993; 29(3):469-72. PubMed ID: 8172468
[TBL] [Abstract][Full Text] [Related]
19. Prognostic risk factors of first recurrence in patients with primary stages I-II cutaneous malignant melanoma - from the population-based Swedish melanoma register.
Lyth J; Falk M; Maroti M; Eriksson H; Ingvar C
J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1468-1474. PubMed ID: 28419674
[TBL] [Abstract][Full Text] [Related]
20. Problems in assessing multiple cutaneous melanoma. A review on the accuracy of a population based cancer registry.
Måsbäck A; Andersson G; Olsson H
Cancer Epidemiol; 2010 Jun; 34(3):262-6. PubMed ID: 20346747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
